骨质松丁:在异常性肺纤维化症中是一种必不可少的调节蛋白
Xiaoyu Zhu1,2, Jie Ji1,2, Xiaodong Han3,4
1Immunology and Reproduction Biology Laboratory & State Key Laboratory of Analytical Chemistry for Life Science, Medical School, Nanjing University, Hankou Road 22, Nanjing, 210093, China.
Journal of molecular histology
|October 25, 2023
概括
异形性肺纤维化 (IPF) 涉及纤维细胞激活和细胞外基质 (ECM) 积累. 骨质松 (OPN) 在IPF病变发生过程中发挥着关键作用,提供了潜在的治疗点.
科学领域:
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 异形性肺纤维化 (IPF) 是一种进展性肺病,治疗选择不佳.
- IPF的特点是纤维细胞激活,过度的细胞外基质 (ECM) 沉积和炎症.
- 一种ECM蛋白质的骨质素 (OPN) 越来越多地因其在纤维性疾病中的作用而得到认可.
研究的目的:
- 审查骨质疏松素 (OPN) 在异形性肺纤维化 (IPF) 中的作用.
- 探索OPN在IPF中的炎症,ECM沉积和上皮-介质细胞过渡 (EMT) 的参与.
- 为开发针对OPN的新型IPF治疗方法提供理论基础.
主要方法:
- 对研究骨质疏松素 (OPN) 在异常性肺纤维化 (IPF) 中的研究的文献综述.
- 分析OPN在纤维细胞激活和ECM产生中的功能.
- 在IPF模型中检查OPN在炎症途径和上皮-介质细胞过渡 (EMT) 中的作用.
主要成果:
- 骨质疏松素 (OPN) 在IPF中促进纤维细胞增殖和细胞外基质 (ECM) 积累.
- OPN有助于IPF特有的炎症环境.
- OPN信号涉及到上皮层-介质细胞过渡 (EMT),这是IPF纤维化中的一个关键过程.
结论:
- 骨质松 (OPN) 是异常性肺纤维化 (IPF) 病变的关键调解者.
- 向性骨质疏松剂 (OPN) 是IPF的一种有前途的治疗策略.
- 对OPN途径的进一步研究可能会导致有效的IPF治疗方法.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Pulmonary Hypertension: Classification and Pathogenesis
194
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
194
COPD: Pathogenesis and Clinical Features
305
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
305
Phosphoinositides and PIPs
8.6K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.6K
Pneumonia II: Pathophysiology
296
The pathophysiology of pneumonia involves the following steps:
296
Cystic Fibrosis: Pathogenesis
256
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
256


